Murchinson’s Amedisys AMED Stock Holding History

Murchinson’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-105,376	Closed	-$10.2M	–	58
2024 Q3	$10.2M	Sell	105,376 -18,603	-15%	-$1.82M	2.76%	12
2024 Q2	$11.4M	Buy	123,979 +50,716	+69%	+$4.71M	1.76%	14
2024 Q1	$6.75M	Buy	+73,263	New	+$6.87M	0.57%	26

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Murchinson's AMED Position: Q4 2024 in Review

Murchinson sold out of Amedisys (AMED) in Q4 2024, closing a stake of 105,376 shares — an estimated $10.2M sold.

Murchinson first reported a position in AMED in Q1 2024 and held it in 3 quarters. The position peaked at $11.4M in Q2 2024. 292 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

Murchinson reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
Murchinson sold 105,376 Amedisys shares in Q4 2024, an estimated $10.2M.
Murchinson first reported a position in Amedisys in Q1 2024 and held it in 3 quarters.
Murchinson's Amedisys position peaked at $11.4M in Q2 2024.
292 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Murchinson's 13F filing for Q4 2024, filed 14 Feb 2025.